Pulmonary Medicine

Episodes 16-30 of 71

• 

  RestartResume

  Risk and How Risk Directs Treatment: Challenges and Barriers to Risk Stratification

  MinuteCE®

  Risk and How Risk Directs Treatment: Challenges and Barriers to Risk Stratification

  • 

    

    Ioana Preston, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Strategies to Implement Risk Stratification in the PH Clinic

  MinuteCE®

  Strategies to Implement Risk Stratification in the PH Clinic

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  • 

    

    Ioana Preston, MD

    Peer

  1.00 program credits

• 

  MinuteCE®

  Integrating Evidence for Improved Outcomes in PH

  • 

    

    Richard N. Channick, MD

    Peer

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  • 

    

    Ioana Preston, MD

    Peer

  • 

    

    Kelly Chin, MD, MSCA

    Peer

  • 

    

    Richard Krasuski, MD

    Peer

  1.50 credits 6 episodes

• 

  RestartResume

  Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension

  MinuteCE®

  Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  1.50 program credits

• 

  RestartResume

  The Promise of Sotatercept in PAH

  MinuteCE®

  The Promise of Sotatercept in PAH

  • 

    

    Ioana Preston, MD

    Peer

  1.50 program credits

• 

  RestartResume

  Macitentan Update: Impact on Management of Pulmonary Hypertension

  MinuteCE®

  Macitentan Update: Impact on Management of Pulmonary Hypertension

  • 

    

    Richard N. Channick, MD

    Peer

  1.50 program credits

• 

  RestartResume

  Update in Pediatric Pulmonary Hypertension

  MinuteCE®

  Update in Pediatric Pulmonary Hypertension

  • 

    

    Richard Krasuski, MD

    Peer

  1.50 program credits

• 

  RestartResume

  Updates on Pulmonary Hypertension Clinical Trials

  MinuteCE®

  Updates on Pulmonary Hypertension Clinical Trials

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  1.50 program credits

• 

  RestartResume

  Vasoreactivity in Pulmonary Hypertension

  MinuteCE®

  Vasoreactivity in Pulmonary Hypertension

  • 

    

    Kelly Chin, MD, MSCA

    Peer

  1.50 program credits

• 

  MinuteCE®

  The Next Generation of Risk Stratification in Patients With PH

  • 

    

    Jean M. Elwing, MD

    Peer

  • 

    

    Richard N. Channick, MD

    Peer

  • 

    

    Victor Moles, MD

    Peer

  1.00 credits 4 episodes

• 

  RestartResume

  Don’t Wait to Escalate—Getting Aggressive in PH Management

  MinuteCE®

  Don’t Wait to Escalate—Getting Aggressive in PH Management

  • 

    

    Jean M. Elwing, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Finding the Patient With PH Among Us: How We Optimize Treatment Based on Patient Type

  MinuteCE®

  Finding the Patient With PH Among Us: How We Optimize Treatment Based on Patient Type

  • 

    

    Richard N. Channick, MD

    Peer

  1.00 program credits

• 

  RestartResume

  PH Management Into the Future: Understanding the Next Generation of Treatments and Mechanisms

  MinuteCE®

  PH Management Into the Future: Understanding the Next Generation of Treatments and Mechanisms

  • 

    

    Victor Moles, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Practical Implications of New Treatments in Clinical Practice

  MinuteCE®

  Practical Implications of New Treatments in Clinical Practice

  • 

    

    Jean M. Elwing, MD

    Peer

  • 

    

    Richard N. Channick, MD

    Peer

  • 

    

    Victor Moles, MD

    Peer

  1.00 program credits

• 

  RestartResume

  IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue

  CME/CE

  IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue

  • 

    

    Amita Sharma, MBBS

    Peer

  • 

    

    Guy Katz, MD

    Peer

  0.50 credits

• Prev
• 1
• 2
• 3
• 4
• 5
• Next